Teligent, Inc. (NASDAQ:TLGT) Director Steven H. Koehler purchased 5,000 shares of Teligent stock in a transaction dated Friday, November 10th. The stock was acquired at an average cost of $3.62 per share, with a total value of $18,100.00. Following the completion of the acquisition, the director now directly owns 1,800 shares in the company, valued at $6,516. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.
Shares of Teligent, Inc. (NASDAQ:TLGT) traded up $0.15 during mid-day trading on Thursday, reaching $3.51. The company had a trading volume of 838,157 shares, compared to its average volume of 418,130. Teligent, Inc. has a 52-week low of $2.82 and a 52-week high of $9.54. The company has a quick ratio of 3.71, a current ratio of 3.28 and a debt-to-equity ratio of 2.23.
Teligent (NASDAQ:TLGT) last issued its quarterly earnings data on Monday, November 6th. The company reported ($0.08) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.01) by ($0.07). The firm had revenue of $13.65 million for the quarter, compared to analyst estimates of $19.12 million. Teligent had a negative return on equity of 6.51% and a negative net margin of 16.95%. The business’s revenue for the quarter was down 15.5% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.01 earnings per share. research analysts predict that Teligent, Inc. will post -0.13 earnings per share for the current year.
Several brokerages recently issued reports on TLGT. Canaccord Genuity reaffirmed a “buy” rating and set a $11.00 price objective on shares of Teligent in a report on Tuesday, August 8th. Roth Capital set a $9.00 price objective on Teligent and gave the stock a “buy” rating in a report on Wednesday, August 9th. BidaskClub cut Teligent from a “hold” rating to a “sell” rating in a report on Monday, July 24th. ValuEngine cut Teligent from a “hold” rating to a “sell” rating in a report on Tuesday, July 25th. Finally, TheStreet cut Teligent from a “c-” rating to a “d+” rating in a report on Wednesday, November 1st. Three research analysts have rated the stock with a sell rating, two have issued a hold rating and one has assigned a buy rating to the company. Teligent has a consensus rating of “Hold” and a consensus target price of $7.33.
A number of institutional investors have recently added to or reduced their stakes in the business. Rhumbline Advisers increased its position in Teligent by 0.4% during the second quarter. Rhumbline Advisers now owns 49,622 shares of the company’s stock worth $454,000 after buying an additional 200 shares in the last quarter. Wells Fargo & Company MN increased its position in Teligent by 3.1% during the first quarter. Wells Fargo & Company MN now owns 45,617 shares of the company’s stock worth $357,000 after buying an additional 1,369 shares in the last quarter. American International Group Inc. increased its position in Teligent by 7.1% during the first quarter. American International Group Inc. now owns 25,488 shares of the company’s stock worth $199,000 after buying an additional 1,680 shares in the last quarter. Voya Investment Management LLC increased its position in Teligent by 16.1% during the second quarter. Voya Investment Management LLC now owns 23,342 shares of the company’s stock worth $214,000 after buying an additional 3,234 shares in the last quarter. Finally, Bank of America Corp DE increased its position in Teligent by 9.1% during the first quarter. Bank of America Corp DE now owns 39,458 shares of the company’s stock worth $307,000 after buying an additional 3,293 shares in the last quarter. 65.85% of the stock is owned by institutional investors.
Teligent, Inc is a specialty generic pharmaceutical company. Under the Company’s own label, it markets and sells generic injectable pharmaceutical products in the United States and Canada. In the United States it marketed 16 generic topical pharmaceutical products and four branded generic pharmaceutical products, as of December 31, 2016.
Receive News & Ratings for Teligent Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teligent Inc. and related companies with MarketBeat.com's FREE daily email newsletter.